Su et al. showed that in 342 HRD-positive HGSOC cases with BRCA1/2 mutations, a higher tumor stage correlated with higher HRD scores, with the score elevating from stage I to III and slightly declining at stage IV [30]. The gene discussed is BRCA1; the disease is neoplasm.